Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Comparison Between Socket Shield and Conventional Techniques in Immediate Implant Placement.

NCT07761442 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-10-20
Last updated
2026-08-12

Condition(s) studied

Bone DensityBone LevelPeri-Implant TissuesSocket Shield Technique Implant PlacementImmediate Implant PlacementRoot Submergence TechniqueSingle Tooth Lost

Investigational drug(s) / intervention(s)

Conventional TechniqueSocket-Shield Technique

Conventional Technique: Immediate Implant Placement Using Conventional Technique

Socket-Shield Technique: Immediate Implant Placement Using Socket-Shield Technique

Study summary

The goal of this randomized clinical trial is to compare whether immediate implant placement using the socket-shield technique can better preserve bone density, bone level, and peri-implant tissue health compared to conventional immediate implant placement in patients requiring tooth extraction in the maxillary esthetic zone.

This study is conducted in systemically healthy adult patients aged 20-60 years who have non-restorable maxillary anterior teeth indicated for immediate implant placement.

The main questions this study aims to answer are:

Does the socket-shield technique result in better peri-implant bone density and bone level preservation compared to the conventional immediate implant technique?

Does the socket-shield technique lead to improved clinical peri-implant parameters, including probing depth, bleeding on probing, keratinized tissue width, and soft tissue thickness?

participants will be divided into two groups: (both groups will receive immediate implant placement of a tooth requiring extraction in the maxillary esthetic zone.) First group: will recieve immediate implant using conventional technique. second group: will recieve immediate implant using socket shield technique.

Participants will:

* Undergo clinical and radiographic examinations, including cone beam computed tomography (CBCT).
* Receive immediate implant placement using either the conventional technique or the socket-shield technique.
* Be followed up clinically and radiographically for 9 months to assess bone and soft tissue healing.
* Attend regular postoperative and follow-up visits for evaluation of implant stability and peri-implant tissue health.

Eligibility

Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged between 20 and 60 years of both genders * All participants should be systemically healthy, as assessed using the dental modification of the Cornell Medical Index. * Gingival and periodontal health to be confirmed according to the criteria outlined in the new classification system proposed by Caton et al. (2018). * Presence of non-restorable teeth due to trauma, complicated crowns or root fractures. * Presence of extensive destructive caries making the tooth unsalvageable, particularly in esthetic zones. * Clinical indication for immediate implant placement, especially in cases where minimizing post-extraction bone resorption and soft tissue collapse is critical. * Availability of adequate interocclusal space to accommodate the necessary prosthetic components without occlusal interference. Exclusion Criteria: (for socket-shield technique) * Pregnant female. * Patients with parafunctional habits (e.g., bruxism, clenching). * Smokers. * Teeth with clinical mobility. * Teeth with root fractures extending below the alveolar bone level. * Periodontal ligament space widening. * Signs of internal or external root resorption. * Current or previous periodontal disease

Primary outcome measure(s)

  • Change in Bone Density Around Immediate Implants. — At baseline of implant placement then after 9 months
    Assessment of bone mineral density using Gray scale values (GSV) derived from Cone Beam Computed Tomography (CBCT) scans. Measurements will be evaluated at the buccal bone adjacent to the retained root fragment (Socket Shield Group) and adjacent to the implant surface (Conventional Immediate Placement Group). The change will be calculated by subtracting the baseline value from the 9-month follow-up value. Unit of Measure: Gray scale values Time Frame: Baseline to 9 months post-implant placement Measure Description: Bone density measured using average gray values extracted from CBCT DICOM files at the buccal aspect of the implant site. Gray scale values reflect the radiographic attenuation/pixel intensity of the surrounding bone.
  • Change in Marginal Bone Level Around Immediate Implants. — At baseline of implant placement then after 9 months.
    * Linear measurement of the distance from the implant platform to the first bone-to-implant contact point to assess crestal bone stability. * Unit of measure : Millimeters (mm).

Trial sites (1)

FacilityCityRegionStatus
Minia University Minya Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07761442 on ClinicalTrials.gov ↗ ← All trials in Egypt